M2 phenotypic markers, such as CCL22, HIF-1a, Ym1, and MMP-9, which are involved in immunosuppression, angiogenesis, epithelial–mesenchymal transition, and invasion [27,28], were significantly upregulated by tumor challenge compared to the WT group. This evidence concerns the gene MMP9 and neoplasm.